Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples